Lixte Biotechnology Holdings, Inc. Common Stock earnings per share and revenue
On 12 de nov. de 2025, LIXT reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Lixte Biotechnology Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lixte Biotechnology Holdings, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Lixte Biotechnology Holdings, Inc. Common Stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Lixte Biotechnology Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for 23 de mar. de 2026.
What are the forecasts for Lixte Biotechnology Holdings, Inc. Common Stock's next earnings report?
Based on --
analistas, Lixte Biotechnology Holdings, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.